Dr. Crane's Regenerative Approach
Regenerative medicine for neuropathic spine pain focuses on creating a biological environment that supports nerve healing. The treatments we use deliver neurotrophic factors - brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and glial cell-derived neurotrophic factor (GDNF) - that support nerve survival, reduce neuroinflammation, and promote axonal repair. When delivered to the epidural space or perineural environment, these biologics create a milieu that favors nerve healing rather than ongoing inflammation.
Regenerative cellular therapy provides additional immunomodulatory benefit. Mesenchymal cells shift macrophage phenotype from M1 (pro-inflammatory) to M2 (pro-healing), reducing the chronic inflammatory state around damaged nerve roots. This immunomodulatory effect addresses one of the key drivers of persistent neuropathic pain.
Emerging research on exosome-mediated neuroprotection suggests that exosomes derived from mesenchymal stem cells carry microRNA and bioactive molecules that can modulate neural inflammation at the molecular level. This is an area of active investigation with promising early results.
Critically, I also address any residual structural contributors. If a patient has neuropathic pain from chronic nerve root compression, treating the nerve alone without addressing the disc or stenosis causing the compression is incomplete. The regenerative approach treats both the structural cause and the neural consequence.
What to Expect
Evaluation includes a detailed neurological examination, imaging review, and electrodiagnostic studies when indicated to characterize the neuropathic component. Treatment is delivered under image guidance to ensure precise delivery to the perineural environment.
Nerve tissue heals on its own timeline. We track neurological symptoms carefully, including pain quality, sensory changes, and functional capacity.